227 related articles for article (PubMed ID: 30247463)
21. Development of an
Lee J; Shin D; Roh JL
Theranostics; 2018; 8(14):3964-3973. PubMed ID: 30083273
[TBL] [Abstract][Full Text] [Related]
22. Large-scale pharmacological profiling of 3D tumor models of cancer cells.
Mathews Griner LA; Zhang X; Guha R; McKnight C; Goldlust IS; Lal-Nag M; Wilson K; Michael S; Titus S; Shinn P; Thomas CJ; Ferrer M
Cell Death Dis; 2016 Dec; 7(12):e2492. PubMed ID: 27906188
[TBL] [Abstract][Full Text] [Related]
23. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.
Yoshii Y; Furukawa T; Waki A; Okuyama H; Inoue M; Itoh M; Zhang MR; Wakizaka H; Sogawa C; Kiyono Y; Yoshii H; Fujibayashi Y; Saga T
Biomaterials; 2015 May; 51():278-289. PubMed ID: 25771018
[TBL] [Abstract][Full Text] [Related]
24. Applicability of tumor spheroids for
Hamilton G; Rath B
Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):15-23. PubMed ID: 30484335
[No Abstract] [Full Text] [Related]
25. Bionic 3D spheroids biosensor chips for high-throughput and dynamic drug screening.
Wu Q; Wei X; Pan Y; Zou Y; Hu N; Wang P
Biomed Microdevices; 2018 Sep; 20(4):82. PubMed ID: 30220069
[TBL] [Abstract][Full Text] [Related]
26. Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.
Meier-Hubberten JC; Sanderson MP
Methods Mol Biol; 2019; 1953():163-179. PubMed ID: 30912022
[TBL] [Abstract][Full Text] [Related]
27. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
[TBL] [Abstract][Full Text] [Related]
28. A 1536-Well 3D Viability Assay to Assess the Cytotoxic Effect of Drugs on Spheroids.
Madoux F; Tanner A; Vessels M; Willetts L; Hou S; Scampavia L; Spicer TP
SLAS Discov; 2017 Jun; 22(5):516-524. PubMed ID: 28346088
[TBL] [Abstract][Full Text] [Related]
29. A Novel Three-Dimensional Immune Oncology Model for High-Throughput Testing of Tumoricidal Activity.
Sherman H; Gitschier HJ; Rossi AE
Front Immunol; 2018; 9():857. PubMed ID: 29740450
[TBL] [Abstract][Full Text] [Related]
30. Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient.
Mulholland T; McAllister M; Patek S; Flint D; Underwood M; Sim A; Edwards J; Zagnoni M
Sci Rep; 2018 Oct; 8(1):14672. PubMed ID: 30279484
[TBL] [Abstract][Full Text] [Related]
31. Generation of uniform-sized multicellular tumor spheroids using hydrogel microwells for advanced drug screening.
Lee JM; Park DY; Yang L; Kim EJ; Ahrberg CD; Lee KB; Chung BG
Sci Rep; 2018 Nov; 8(1):17145. PubMed ID: 30464248
[TBL] [Abstract][Full Text] [Related]
32. Automated Assessment of Cancer Drug Efficacy On Breast Tumor Spheroids in Aggrewell™400 Plates Using Image Cytometry.
Mukundan S; Bell J; Teryek M; Hernandez C; Love AC; Parekkadan B; Chan LL
J Fluoresc; 2022 Mar; 32(2):521-531. PubMed ID: 34989923
[TBL] [Abstract][Full Text] [Related]
33. Reproducibility of Uniform Spheroid Formation in 384-Well Plates: The Effect of Medium Evaporation.
Das V; Fürst T; Gurská S; Džubák P; Hajdúch M
J Biomol Screen; 2016 Oct; 21(9):923-30. PubMed ID: 27226477
[TBL] [Abstract][Full Text] [Related]
34. The Generation of Three-Dimensional Head and Neck Cancer Models for Drug Discovery in 384-Well Ultra-Low Attachment Microplates.
Close DA; Camarco DP; Shan F; Kochanek SJ; Johnston PA
Methods Mol Biol; 2018; 1683():355-369. PubMed ID: 29082502
[TBL] [Abstract][Full Text] [Related]
35. Development, validation and pilot screening of an in vitro multi-cellular three-dimensional cancer spheroid assay for anti-cancer drug testing.
Lama R; Zhang L; Naim JM; Williams J; Zhou A; Su B
Bioorg Med Chem; 2013 Feb; 21(4):922-31. PubMed ID: 23306053
[TBL] [Abstract][Full Text] [Related]
36. Robotic printing and drug testing of 384-well tumor spheroids.
Ham SL; Thakuri PS; Tavana H
Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():2183-6. PubMed ID: 26736723
[TBL] [Abstract][Full Text] [Related]
37. The multicellular tumor spheroid model for high-throughput cancer drug discovery.
LaBarbera DV; Reid BG; Yoo BH
Expert Opin Drug Discov; 2012 Sep; 7(9):819-30. PubMed ID: 22788761
[TBL] [Abstract][Full Text] [Related]
38. Real-Time Apoptosis and Viability High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Qiu J; Chan LL
SLAS Discov; 2018 Feb; 23(2):202-210. PubMed ID: 28915356
[TBL] [Abstract][Full Text] [Related]
39. Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays.
Raghavan S; Ward MR; Rowley KR; Wold RM; Takayama S; Buckanovich RJ; Mehta G
Gynecol Oncol; 2015 Jul; 138(1):181-9. PubMed ID: 25913133
[TBL] [Abstract][Full Text] [Related]
40. Issues with Cancer Spheroid Models in Therapeutic Drug Screening.
Fröhlich E
Curr Pharm Des; 2020; 26(18):2137-2148. PubMed ID: 32067603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]